Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
1.
Transplant Proc ; 48(2): 315-8, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27109944

ABSTRACT

BACKGROUND: Dual kidney transplantation (DKT) is a largely accepted strategy to enlarge the donor pool. Niguarda Hospital started this program in December 2010, and 38 DKT have been performed. In our series, we included recipients older than those in the other series published in literature. The aim of this study was to know if our recipient selection criteria for DKT are safe. METHODS: We reviewed our data base of DKT and analyzed recipients' medical history, surgical technique, post-operative complications, graft survival, morbidity, and mortality. We then compared our results with the literature. RESULTS: From December 2010 to April 2015, 38 DKT were performed in Niguarda Hospital. Delayed graft function was present in 21 recipients. Explantation of both kidneys was performed in 1 patient and explantation of 1 kidney in 6 patients. Post-operative complications were present in 8 patients. Five patients returned to hemodialysis after DKT. One recipient died of medical post-operative sepsis. The mean follow-up was 24 months. Graft survival and patient survival were 86.84% and 97.93%, respectively. Compared with the literature, our series had similar mortality and morbidity rates, even if recipients' age was higher than in other series. CONCLUSIONS: The strategy of DKT allocation in elderly recipients is safe. Further studies have to be performed to optimized selection of the recipients for DKT not to disadvantage younger patients in the transplant waiting list and to improve the technique of organ evaluation and preservation to refine graft allocation.


Subject(s)
Hospitals/statistics & numerical data , Kidney Transplantation/statistics & numerical data , Patient Selection , Age Factors , Aged , Delayed Graft Function/epidemiology , Delayed Graft Function/etiology , Female , Graft Survival , Humans , Italy , Kidney/physiopathology , Kidney Transplantation/adverse effects , Kidney Transplantation/methods , Male , Middle Aged , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies , Tissue Donors/supply & distribution
2.
J Neurosurg Sci ; 55(4): 357-63, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22198587

ABSTRACT

AIM: The aim of the study was to present the incidence of early and late surgical complications in a group of patients treated with anterior approach for spine lesions. The study was also focused on technical aspects for lesions of D1-D2 and L5-S1 segments and results on a group of patients underwent adjunctive surgical procedures at the same time of spinal surgery. METHODS: This was a retrospective study based on our database from April 1998 to December 2008. The study enrolled 120 consecutive patients (M/F 73/47; mean age 43.1 years; range 15-70 years) who underwent spinal surgery for trauma (92 patients), primitive or metastatic cancer (12 patients), benign lesion (2 patients), degenerative disc disease (6 patients) and infection disease (8 patients). This work describes the anterior approach to the spine. RESULTS: No death was recorded. Thirty-two patients (26.6%) presented postoperative complications: persistent urinary tract infections in 19 (15.9%), pneumonia in 6 (5%), pleural effusion in 3 (2.5%), wound infection in 2 (1.6%), retro-peritoneal abscess in 1 (0.8%) and haemorrhage in 1 (0.8%). During the follow-up (mean 3.8 years; range 2 months-10 years) 1 patient (0.8%) required two further surgical procedures for tuberculosis abscess recurrences. CONCLUSION: Anterior approach to the spine is effective and safe. Surgical complications do not negatively affect patient survival and spine stabilization included patients with D1-D2 and L5-S1 lesion and patients who receive adjunctive surgery at the same time of spine procedure.


Subject(s)
Intervertebral Disc/surgery , Orthopedic Procedures/adverse effects , Postoperative Complications/epidemiology , Spinal Cord/surgery , Spine/surgery , Adolescent , Adult , Aged , Female , Humans , Incidence , Lumbar Vertebrae/surgery , Male , Middle Aged , Orthopedic Procedures/methods , Retrospective Studies , Thoracic Vertebrae/surgery
3.
Vet Microbiol ; 132(3-4): 302-11, 2008 Dec 10.
Article in English | MEDLINE | ID: mdl-18565697

ABSTRACT

Brucella abortus M1-luc is a mutant strain derived from S19 vaccine strain in which most of bp26 sequence has been replaced by the luciferase coding gene. Strain I2 is a double mutant derived from M1-luc in which most of omp19 has been deleted without introduction of any genetic markers. In BALB/c mice, M1-luc presented equivalent performance to S19 regarding persistence, splenomegaly and protection against challenge. Interestingly, I2 was more attenuated than S19, with no reduction of protection against challenge. In order to evaluate the potential for vaccine use of these strains in the natural host, four groups of 15 heifers, 6-month old, were either non-vaccinated or vaccinated with S19, M1-luc or I2. To at reached 17-month old, heifers were synchronized with two doses of PGF2alpha and received natural service during 60 days with two bulls. Pregnant heifers were challenged at approximately six gestation months with virulent B. abortus S2308. Blood samples post-challenge of heifers were collected for serologic test as well as specimens of aborted fetuses and premature calves for bacterial isolation and histopathological analyses. Protection levels against abortion were 78.6% for S19, 81.8% for M1-luc and 45.5% for I2, compared to the 25% that did not abort from the non-vaccinated group. These results indicate that in bovines BP26 had no influence in protective capacity of S19, correlating with the results obtained in mice. However, contrarily to what was previously observed in mice, lack of expression of Omp19 rendered in less protection capacity of S19 in the natural host.


Subject(s)
Bacterial Vaccines/immunology , Brucella abortus/immunology , Brucellosis, Bovine/prevention & control , Animals , Cattle , Female
4.
Transplant Proc ; 39(6): 1820-2, 2007.
Article in English | MEDLINE | ID: mdl-17692621

ABSTRACT

To satisfy the increasing requests for renal grafts, elderly donors are increasingly accepted for kidney transplant at many centers. The main unresolved question is the long-term effect on graft survival of potential histological lesions due to donor age. We present a prospective histological study performed from January 1997 to December 2001 on 184 consecutively transplanted renal grafts in which the only criterion for graft acceptance was a normal value of serum creatinine upon admission to the intensive care unit independent of donor age. At the end of the study, 57 recipients (31%) of mean age 55 years (range 39 to 67 years) received a renal graft from donors aged more than 60 years (mean age 66 years; range 60 to 75 years), this cohort denoted as older donor kidney transplant group (ODKTG) and 127 recipients (69%) with a mean age of 49 years (range 21 to 63 years) received a renal graft from donors whose age was lower than 60 years (mean age 49 years; range 16 to 59 years), a cohort denoted as the younger donor kidney transplant group (YDKTG). The two groups were comparable for time of dialysis, cold ischemia time, immunosuppression therapy, grading of histological damage. At the end of the study with a mean follow-up of 5.6 years (range 3.5 to 7.5 years), primary graft nonfunction and delayed graft function were significantly more represented in the ODKTG than the YDKTG. Cumulative patient and graft survival was 84.3% and 79.4% in the ODKTG, respectively, and 93.8% and 85.9% in the YDKTG, respectively (P = NS). Cumulative serum creatinine values were 1.98 mg/100 mL in ODKTG and 1.65 mg/100 mL in YDKTG (P = NS). In conclusion, renal grafts from older donors presented histological damage comparable to that seen among renal grafts from younger donors.


Subject(s)
Aging/physiology , Kidney Transplantation/physiology , Tissue Donors/statistics & numerical data , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Creatinine/blood , Graft Rejection/epidemiology , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/mortality , Length of Stay , Middle Aged , Prospective Studies , Survival Analysis , Treatment Outcome
5.
Transplant Proc ; 38(4): 994-5, 2006 May.
Article in English | MEDLINE | ID: mdl-16757241

ABSTRACT

Living donation in the field of renal transplantation has increased over time as well as the use of laparoscopic nephrectomy. We present a 15-year experience on 162 living donors (105 women, 57 men; mean age, 46.7 years; range, 31-74 years) who underwent nephrectomy using different surgical approaches as open lombotomic nephrectomy (OLN), open transperitoneal nephrectomy (OTN), and laparoscopic hand-assisted nephrectomy (LHAN). We collected data on residual donor and recipient renal function, as well as early versus late medical and surgical complications. With a mean follow-up of about 8 years, we observed normal residual renal function in all donors and similar results of early and late graft function independent of the surgical procedure. Long-term incidence of hypertension and noninsulin-dependent diabetes in living donors was similar to the general population. OLN and OTN donors showed higher incidences of early and late complications, readmissions, and reoperations than LHAN donors. Our results confirmed that living donor nephrectomy is a safe procedure without serious side effects in terms of renal function and long-term quality of life. LHAN should be the preferred technique because of a lower incidence of early and late complications.


Subject(s)
Kidney Function Tests , Kidney/physiology , Living Donors , Nephrectomy/adverse effects , Tissue and Organ Harvesting/adverse effects , Follow-Up Studies , Hemorrhage/etiology , Humans , Laparoscopy/adverse effects , Laparoscopy/methods , Nephrectomy/methods , Postoperative Complications/classification , Reoperation , Retrospective Studies , Time Factors , Treatment Outcome
6.
Transplant Proc ; 38(4): 1153-5, 2006 May.
Article in English | MEDLINE | ID: mdl-16757292

ABSTRACT

Surgical complications are the leading cause of pancreatic graft loss among diabetic patients who undergo pancreas transplantation alone (PTA), or combined with kidney transplantations (PK) or after kidney transplantations (PAK). Therapeutic effects on secondary complications of diabetes justify pancreas retransplantation (re-PT) when the first graft is lost. However, the appropriate timing for retransplant and related problems is not known. We present our initial experience on re-PT performed on seven diabetic patients who lost their first pancreas grafts (PK) due to surgical complications (venous thrombosis in five and enteric fistula in two). Five re-PT were performed a few days after the first PT without a second course of induction therapy, while two patients received re-PT some months later with reinduction therapy. In the early re-PT group, one patient died some hours after the second surgical procedure due to pulmonary embolism, while four patients lost their second grafts due to accelerated rejection within 2 years from re-PT. In the late re-PT group, both patients have good graft function without signs of rejection. Our initial experience showed discouraging results in the group of early re-PT, due to accelerated rejection episodes leading to a high incidence of graft loss. Late re-PT accompanied by reinduction therapy seemed to have better results.


Subject(s)
Pancreas Transplantation/methods , Pancreas Transplantation/statistics & numerical data , Graft Survival , Humans , Pancreas Transplantation/physiology , Postoperative Period , Reoperation/statistics & numerical data , Retrospective Studies , Treatment Failure , Treatment Outcome
7.
J Endocrinol Invest ; 28(1): 72-8, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15816375

ABSTRACT

Intraoperative [111In]-pentetreotide scintigraphy with a hand-held gamma detector probe has recently been proposed to increase the intraoperative detection rate of small neuroendocrine tumors and their metastases. We report a case of a 28-yr-old woman with ectopic Cushing's syndrome due to an ACTH-secreting bronchial carcinoid, in whom the use of radioguided surgery improved disease management. At presentation, radiolabeled pentetreotide scintigraphy was the only procedure able to detect the ectopic source of ACTH. After radiologic confirmation, the patient underwent removal of a bronchial carcinoid, with disease persistence. After surgery, pentetreotide scintigraphy showed pathologic uptake in the mediastinum not previously detected at surgery and only subsequently confirmed by radiologic studies. Despite a second thoracic exploration, hormonal, scintigraphic, and radiological evidence of residual disease persisted. Radioguided surgery was then performed using a hand-held gamma probe 48 h after iv administration of a tracer dose of radiolabeled [111In-DTPA-D-Phe1]-pentetreotide, which permitted detection and removal of multiple residual mediastinal lymph node metastases. Clinical and radiologic cure, with no evidence of tracer uptake at pentetreotide scintigraphy, was subsequently observed. The use of an intraoperative gamma counter appears a promising procedure in the management of metastatic ACTH-secreting bronchial carcinoids.


Subject(s)
ACTH Syndrome, Ectopic/diagnostic imaging , ACTH Syndrome, Ectopic/surgery , Bronchial Neoplasms/diagnostic imaging , Bronchial Neoplasms/surgery , Carcinoid Tumor/diagnostic imaging , Carcinoid Tumor/surgery , Cushing Syndrome/etiology , Radiopharmaceuticals , Somatostatin/analogs & derivatives , Surgery, Computer-Assisted , ACTH Syndrome, Ectopic/etiology , Adrenocorticotropic Hormone/blood , Adult , Biomarkers , Bronchial Neoplasms/complications , Carcinoid Tumor/complications , Corticotropin-Releasing Hormone , Deamino Arginine Vasopressin , Female , Hormones/blood , Humans , Hydrocortisone/blood , Luminescent Measurements , Lymphatic Metastasis , Mediastinal Neoplasms/surgery , Octreotide , Radionuclide Imaging , Stimulation, Chemical , Tomography, X-Ray Computed
8.
J Clin Endocrinol Metab ; 88(3): 1029-35, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12629081

ABSTRACT

The differential diagnosis and the identification of the source of ACTH in occult ectopic Cushing's syndrome due to a bronchial carcinoid still represents a challenge for the endocrinologist. We report our experience in six patients with occult bronchial carcinoid in whom extensive hormonal, imaging, and scintigraphic evaluation was performed. All patients presented with hypercortisolism associated with high plasma ACTH values. The CRH test and high dose dexamethasone suppression test suggested an ectopic source of ACTH in three of six patients. During bilateral inferior petrosal sinus sampling, none of the patients showed a central to peripheral ACTH gradient. At the time of diagnosis, none of the patients had radiological evidence of the ectopic source of ACTH, whereas pentetreotide scintigraphy identified the lesion in two of four patients. Finally, a chest computed tomography scan revealed the presence of a bronchial lesion in all patients, and pentetreotide scintigraphy identified four of six lesions. In all patients a bronchial carcinoid was found and removed. In one patient with scintigraphic evidence of residual disease after two operations, radioguided surgery, using a hand-held gamma probe after iv administration of radiolabeled pentetreotide, was performed; this allowed detection and removal of residual multiple mediastinal lymph node metastases. In conclusion, our data show that there is not a single endocrine test or imaging procedure accurate enough to diagnose and localize occult ectopic ACTH-secreting bronchial carcinoids. Radioguided surgery appears to be promising in the presence of multiple tumor foci and previous incomplete removal of the tumor.


Subject(s)
Adrenocorticotropic Hormone/metabolism , Bronchial Neoplasms/metabolism , Carcinoid Tumor/metabolism , Somatostatin/analogs & derivatives , Adrenocorticotropic Hormone/blood , Adult , Aged , Bronchial Neoplasms/diagnosis , Bronchial Neoplasms/therapy , Carcinoid Tumor/diagnosis , Carcinoid Tumor/therapy , Corticotropin-Releasing Hormone/pharmacology , Female , Humans , Indium Radioisotopes , Magnetic Resonance Imaging , Male , Middle Aged , Tomography, X-Ray Computed , Treatment Outcome
9.
Infect Immun ; 69(2): 865-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11159979

ABSTRACT

Brucella abortus is the etiological agent of brucellosis, a disease that affects bovines and human. We generated DNA random sequences from the genome of B. abortus strain 2308 in order to characterize molecular targets that might be useful for developing immunological or chemotherapeutic strategies against this pathogen. The partial sequencing of 1,899 clones allowed the identification of 1,199 genomic sequence surveys (GSSs) with high homology (BLAST expect value < 10(-5)) to sequences deposited in the GenBank databases. Among them, 925 represent putative novel genes for the Brucella genus. Out of 925 nonredundant GSSs, 470 were classified in 15 categories based on cellular function. Seven hundred GSSs showed no significant database matches and remain available for further studies in order to identify their function. A high number of GSSs with homology to Agrobacterium tumefaciens and Rhizobium meliloti proteins were observed, thus confirming their close phylogenetic relationship. Among them, several GSSs showed high similarity with genes related to nodule nitrogen fixation, synthesis of nod factors, nodulation protein symbiotic plasmid, and nodule bacteroid differentiation. We have also identified several B. abortus homologs of virulence and pathogenesis genes from other pathogens, including a homolog to both the Shda gene from Salmonella enterica serovar Typhimurium and the AidA-1 gene from Escherichia coli. Other GSSs displayed significant homologies to genes encoding components of the type III and type IV secretion machineries, suggesting that Brucella might also have an active type III secretion machinery.


Subject(s)
Brucella abortus/genetics , DNA, Bacterial/chemistry , Genome, Bacterial
10.
Am J Surg ; 179(3): 182-5, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10827314

ABSTRACT

BACKGROUND: This study evaluated the impact of surgery in the incidence of lymphocele after kidney transplantation (KTx). METHODS: A prospective randomized study was conducted during a 6-year period on a group of patients undergoing KTx and operated on by the same surgeon (CVS). A total of 280 patients undergoing KTx were randomly allocated into two groups: (1) group C (control group) was 140 patients who were submitted to KTx with standard technique: implantation of the kidney in the controlateral iliac fossa with vascular anastomoses on the external iliac vessels; and (2) group M (modified technique group) was 140 patients who underwent a modified technique with a cephalad implantation of the graft in the ipsilateral iliac fossa and vascular anastomoses in the common iliac vessels. Both groups were comparable for age, cold ischemia time, incidence of rejection episodes, presence of adult polycystic kidney disease, and source of donor graft. RESULTS: Group M showed an incidence of lymphocele production (3 patients, 2.1%) significantly lower than group C (12 patients, 8.5%). Eight patients (1 in group M and 7 in group C) required surgical treatment by peritoneal fenestration. No allograft or recipient was lost as a result of fluid collection but the hospitalization was shorter in group M than in group C. CONCLUSIONS: A cephalad implantation of the renal graft in the ipsilateral iliac fossa has been associated with a lower incidence of lymphocele, probably because vascular anastomoses on the common iliac vessels cause less lymphatic derangement than those performed on the external iliac vessels.


Subject(s)
Kidney Transplantation , Lymphocele/prevention & control , Adult , Age Factors , Anastomosis, Surgical/adverse effects , Anastomosis, Surgical/methods , Female , Graft Rejection/classification , Graft Survival , Hospitalization , Humans , Iliac Artery/surgery , Iliac Vein/surgery , Incidence , Kidney Transplantation/adverse effects , Length of Stay , Lymphocele/etiology , Lymphocele/surgery , Male , Peritoneum/surgery , Polycystic Kidney Diseases/surgery , Prospective Studies , Time Factors , Tissue Donors , Tissue Preservation
11.
Clin Diagn Lab Immunol ; 7(1): 114-8, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10618289

ABSTRACT

Using the shuttle vector pMCO2 and the vaccinia virus wild-type WR strain, we constructed a recombinant virus expressing an 18-kDa outer membrane protein of Brucella abortus. BALB/c mice inoculated with this virus produced 18-kDa protein-specific antibodies, mostly of immunoglobulin G2a isotype, and in vitro stimulation of splenocytes from these mice with purified maltose binding protein-18-kDa protein fusion resulted in lymphocyte proliferation and gamma interferon production. However, these mice were not protected against a challenge with the virulent strain B. abortus 2308. Disruption of the 18-kDa protein's gene in vaccine strain B. abortus RB51 did not affect either the strain's protective capabilities or its in vivo attenuation characteristics. These observations suggest that the 18-kDa protein plays no role in protective immunity.


Subject(s)
Bacterial Outer Membrane Proteins/immunology , Brucella abortus/immunology , Immunoglobulin G/biosynthesis , Vaccinia virus/genetics , Vaccinia virus/immunology , Animals , Brucellosis/prevention & control , Female , Interferon-gamma/biosynthesis , Lymphocyte Count/drug effects , Maltose/chemistry , Mice , Mice, Inbred BALB C , Recombinant Proteins/immunology
20.
Infect Immun ; 65(2): 798-800, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9009345

ABSTRACT

This study determines whether a genetically engineered mutant of Brucella abortus, strain M-1, possesses differences in protective properties compared to the parental strain, vaccine S19. M-1 is a mutant unable to express BP26, a periplasmic protein with potential use in diagnosis. Mice vaccinated with S19 developed antibodies against BP26, while those vaccinated with M-1 did not. However, mice vaccinated with S19 or M-1 were similarly protected against challenge with pathogenic strain 2308, suggesting that the lack of BP26 does not affect the induction of the protective immune response exerted by S19. These and previous results showing that bacterial invasion and growth or replication in mouse spleens were indistinguishable between strains M-1 and S19 could indicate that the mutant is an attenuated strain which maintains the same protective properties as S19.


Subject(s)
Brucella Vaccine/genetics , Brucella Vaccine/immunology , Brucella abortus/genetics , Brucellosis/prevention & control , Vaccines, Synthetic/immunology , Animals , Brucella abortus/immunology , Brucellosis/immunology , Female , Mice , Mice, Inbred BALB C , Mutagenesis, Insertional
SELECTION OF CITATIONS
SEARCH DETAIL
...